On ECHEMI
Home > Drugs > Osteosarcoma
Osteosarcoma
Osteosarcoma refers to a malignant connective tissue tumor in which tumor cells can directly produce tumor bone and bone-like tissue. Its incidence ranks first among primary malignant tumors. The tumor is highly malignant and has extremely poor prognosis. It can metastasize to the lungs within a few months, and the survival rate is only 5% to 20% 3 to 5 years after amputation. About three-quarters of all osteosarcomas occur in the lower end of the femur and the upper end of the tibia, and can also occur in other places such as the humerus, upper end of the femur, fibula, spine, ilium, etc. Most are osteolytic, and a few are osteoblastic. Age of onset: It can occur at any age, but mostly between 10 and 25 years old, and more often in men. The tumor is mostly at the end of the bone, and occasionally occurs in the backbone or epiphysis.
  • Site of disease:

    bone
  • Infectious :

    Not contagious
  • Frequent population:

    All people, often in adolescents
  • Related symptoms:

    Severe pain Lung metastasis Knee pain Dyspnea Recurrent fractures in children
  • Concurrent disease:

Related Drugs
Doxorubicin Hydrochloride
Indication: Doxorubicin is an antimitotic cytotoxic drug that can successfully induce remission in a variety of malignancies, including acute leukemias, lymphomas, soft tissue and bone sarcomas, childhood malignancies, and adult solid tumors, especially breast and lung cancer.
Transfer factor injection
Indication: It is clinically used to treat viral or fungal intracellular infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.); it can be used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.); and it has a good therapeutic effect on immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases).
Manufacturer:

KP Pharmacy Co., Ltd.

Transfer factor injection
Indication: It is clinically used to treat viral or fungal intracellular infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.); it can be used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.); and it has a good therapeutic effect on immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases).
Manufacturer:

Hebei Zhitong Biopharmaceutical Co., Ltd.

Transfer factor injection
Indication: It is clinically used to treat viral or fungal intracellular infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.); it can be used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.); and it has a good therapeutic effect on immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases).
Transfer factor injection
Indication: It is clinically used to treat viral or fungal intracellular infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.); it can be used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.); and it has a good therapeutic effect on immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases).
Manufacturer:

Guangzhou Youcare Biopharmaceatics Co., Ltd.

Transfer factor injection
Indication: It is clinically used to treat viral or fungal intracellular infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.); it can be used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.); and it has a good therapeutic effect on immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases).
Manufacturer:

Wuhan Hualong BIO-CHEMICAL Pharmaceutical Co., Ltd.

Transfer factor injection
Indication: It is clinically used to treat viral or fungal intracellular infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.); it can be used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.); and it has a good therapeutic effect on immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases).
Manufacturer:

Hunan Yige Pharmaceutical Co., Ltd.

Doxorubicin Hydrochloride for Injection
Indication: Antimitotic and cytotoxic drugs. Doxorubicin can successfully induce remission in a variety of malignancies, including acute leukemias, lymphomas, soft tissue and bone sarcomas, childhood malignancies, and adult solid tumors, especially breast and lung cancer.
Doxorubicin Hydrochloride for Injection
Indication: It is suitable for the treatment of acute leukemia (lymphocytic and granulocytic), malignant lymphoma, breast cancer, lung cancer (small cell and non-small cell lung cancer), ovarian cancer, bone and soft tissue sarcoma, Wilms' tumor, neuroblastoma, bladder cancer, thyroid cancer, prostate cancer, head and neck squamous cell carcinoma, testicular cancer, gastric cancer, liver cancer, etc.
Manufacturer:

Han Hui Pharmaceuticals Company Limited

Doxorubicin Hydrochloride for Injection
Indication: Antimitotic and cytotoxic drugs. Doxorubicin can successfully induce remission in a variety of malignancies, including acute leukemias, lymphomas, soft tissue and bone sarcomas, childhood malignancies, and adult solid tumors, especially breast and lung cancer.
Manufacturer:

Shanxi PUDE Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.